-
2019년 표적치료연구회 춘계심포지엄
일시 : 2019년 03월 23일 (토)
장소 : 광주 김대중컨벤션센터 4층 컨벤션홀 3
연수평점 : 3점
사회 : 박철규(전남의대)
| Time | Title | Speaker & Chairperson |
|---|---|---|
| 12:20 ~ 12:50 | Registration | |
| 12:50 ~ 12:55 | Greeting | 김영태(대한폐암학회 이사장) |
| 12:55 ~ 13:00 | Opening address | 이민기(표적치료연구회장) |
Section 1: Enhancing treatment decision making in advanced NSCLC |
좌장 : 이계영(건국의대) 장태원(고신의대) |
|
| 13:00 ~ 13:20 | Strategies for treatment selection in EGFR mutant NSCLC based on real world data | 윤성훈(부산의대) |
| 13:20 ~ 13:40 | Emerging blood based biomarkers of immune checkpoint inhibitor response | 박동원(한양의대) |
| 13:40 ~ 13:50 | Q & A | |
| 13:50 ~ 14:10 | Coffee Break | |
|
Section 2: Emerging treatment options in locally advanced NSCLC |
좌장 : 김영철(전남의대) 손춘희(동아의대) |
|
| 14:10 ~ 14:30 | Immunotherapy in surgically resectable NSCLC | 정치영(대구가톨릭의대) |
| 14:30 ~ 14:50 | Consolidation immunotherapy after chemoradiation for unresectable NSCLC | 박찬권(가톨릭의대) |
| 14:50 ~ 15:10 | EGFR-TKI-based vs. non-EGFR-TKI-based adjuvant therapy in resected NSCLC with EGFR mutations | 정재욱(충남의대) |
| 15:10 ~ 15:25 | Q & A | |
| 15:25 ~ 15:40 | Coffee Break | |
|
Section 3: Strategies to overcome hurdles for successful immunotherapy
|
좌장 : 인광호(고려의대) 이민기(부산의대) |
|
| 15:45 ~ 16:05 | Innovative treatments for SCLC | 박철규(전남의대) |
| 16:05 ~ 16:25 | Immune checkpoint inhibitors in challenging populations | 이승현(경희의대) |
| 16:25 ~ 16:45 | The role of immunotherapy in EGFR mutant NSCLC | 선종무(성균관의대) |
| 16:45 ~ 17:00 | Q & A | |
| 17:00 ~ 17:10 | Conferring ceremony of KASTT Research Grant | 이민기(표적치료연구회장) |
| Closing | ||